Proteomics inks exclusive Australian distributor deal with Healius for Promarker blood tests, enabling nationwide rollout by 2027; revenue not yet estimable.

Amaero posts record Q426 revenue of A$7.8m (+417% YoY) as backlog hits A$23.1m; eyed US listing after redomiciling, DoW ...

TG Metals signs non-binding deal with Medallion Metals to process ~60,000t Van Uden gold stockpiles at Cosmic Boy, unlocking ...

Black Canyon hits 41% manganese product in Wandanya pilot DMS tests; 80-82% recoveries, high-grade, bolstering DSO/manganese ...

Radiopharm Theranostics reports durable partial response for RAD204 in Phase 1; RAD101 Phase 2b brain mets shows 93% MRI-PET ...

Horizon Gold (ASX: HRN) has completed a definitive feasibility study (DFS) that sets a development pathway for its wholly ...

MONEYME passes $2B loan book as FY26 originations hit a record; H2 NPAT positive amid improving credit quality and cost ...

Lumos Diagnostics expands FebriDx rollout to 430 US urgent care sites across top accounts, targeting 2.6 million ARI visits ...

Optiscan Imaging pushes Stage 2 of head and neck cancer live-imaging study ahead of schedule, accelerating clinical ...

Plenti posts $536m quarterly originations, up 22% YoY, with June record; automotive, renewable energy and personal lending ...

QuickFee reports flat Q4 FY26 revenue at A$4.4m; Australian Finance TTV up 40% to A$25.1m; FY26 EBITDA guidance A$3.75-4.25m.